ADVERSE
EFFECTS
OF
IODIDES
ON
THYROID
FUNCTION
THE
ADMINISTRATION
OF
PHARMACOLOGIC
QUANTITIES
OF
IODINE
SUCH
AS
IODIDES
FOR
THE
TREATMENT
OF
PULMONARY
DISEASE
ORGANIC
IODINE
PRESENT
IN
MEDICATIONS
AND
XRAY
CONTRAST
DYES
AND
THE
INGESTION
OF
IODINERICH
NATURAL
FOODS
MAY
RESULT
IN
GOITER
HYPOTHYROIDISM
OR
HYPERTHYROIDISM
ESPECIALLY
IN
PATIENTS
WITH
UNDERLYING
THYROID
DISEASE
MEDICATIONS
CONTAINING
IODIDE
MAY
INDUCE
HYPOTHROIDISM
IN
EUTHYROID
PATIENTS
WITH
HASHIMOTOS
THYROIDITIS
131I
OR
SURGICALLY
TREATED
GRAVES
DISEASE
OR
FOLLOWING
HEMITHYROIDECTOMY
FOR
NODULES
AND
THEY
MAY
INDUCE
HYPERTHYROIDISM
IN
PATIENTS
WITH
ENDEMIC
IODINE
DEFICIENT
GOITER
AUTONOMOUS
NODULES
OR
NONTOXIC
NODULAR
GOITER
OR
IN
PATIENTS
RECENTLY
TREATED
WITH
ANTITHYROID
DRUGS
FOR
GRAVES
DISEASE
RARELY
HYPOTHYROIDISM
OR
HYPERTHYROIDISM
MAY
DEVELOP
IN
PATIENTS
WITH
COMPLETELY
NORMAL
THYROID
FUNCTION
DURING
ADMINISTRATION
OF
IODIDE
THE
ETIOLOGY
OF
IODIDEINDUCED
GOITER
AND
HYPOTHYROIDISM
IN
PATIENTS
WITH
CYSTIC
FIBROSIS
REMAINS
OBSCURE
IODIDEINDUCED
MYXEDEMA
MAY
ALSO
OCCUR
IN
PATIENTS
RECEIVING
DRUGS
WHICH
ALTER
THYROID
FUNCTION
SUCH
AS
LITHIUM
PHENAZONE
AND
SULFISOXAZOLE
FINALLY
IODIDES
DO
HAVE
A
ROLE
IN
THE
TREATMENT
OF
HYPERTHYROIDISM
BUT
THEIR
USE
SHOULD
PROBABLY
BE
RESTRICTED
TO
THYROID
STORM
PREOPERATIVE
PREPARATION
OF
THE
HYPERTHYROID
PATIENT
AND
FOLLOWING
131I
TREATMENT
